Corrigendum: Assessing the causal relationship between genetically determined inflammatory biomarkers and low back pain risk: a bidirectional two-sample Mendelian randomization study

Front Immunol. 2023 Nov 14:14:1327338. doi: 10.3389/fimmu.2023.1327338. eCollection 2023.

Wenhan Li¹, Qunwen Lu¹, Junhui Qian^{1

2}, Yue Feng^{3

4}, Jian Luo¹, Caigui Luo¹, Wenshan He⁵, Bing Dong⁶, Huahui Liu⁷, Zhongxing Liu⁸, Chengguo Su³

¹ Tui-Na Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
² Department of Acupuncture, Moxibustion, Tui-Na and Rehabilitation, Guang'an City Hospital of Traditional Chinese Medicine, Guangan, Sichuan, China.
³ Tui-Na Teaching and Research Department, College of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
⁴ Tui-Na Department, Meishan City Hospital of Traditional Chinese Medicine, Meishan, Sichuan, China.
⁵ Rehabilitation Department, School of Clinic Medicine & The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
⁶ Chinese Medicine Rehabilitation Department, Jiahekang Hospital, Luzhou, Sichuan, China.
⁷ Department of Acupuncture, Moxibustion, Tui-Na and Rehabilitation, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, China.
⁸ Center for Traditional Chinese Medicine Prevention and Health Care, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1174656.].

Keywords: Mendelian randomization; causality; inflammatory biomarkers; interleukin 6 (IL-6); low back pain.